Replies to post #99333 on Biotech Values

[DewDiligence]

Unlike rkrw’s joke on April 1, this time it’s for real. Congratulations to MNTA longs!

This calls for an update to the ReadMeFirst :- )

[turtlepower]

MNTA - Here's the FDA link if anyone is interested.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220092.htm

[DewDiligence]

Two observations on NVS/MNTA’s generic Lovenox:

1. It is fully substitutable for Sanofi’s branded product.

2. The indication is DVT prevention, which is Lovenox’s main market. The FDA evidently “carved out” the ACS indication, which was protected by Hatch-Waxman marketing exclusivity until 5/16/10: #msg-43243987. Inasmuch as 5/16/10 has already passed, I think NVS/MNTA’s approval will soon be expanded to include ACS.